Израел - Хебрејски - Ministry of Health

medomie pharma ltd, israel - thiotepa - אבקה להכנת תמיסה מרוכזת לעירוי - thiotepa 100 mg/vial - thiotepa

Израел - Хебрејски - Ministry of Health

medomie pharma ltd, israel - thiotepa - אבקה להכנת תמיסה מרוכזת לעירוי - thiotepa 15 mg/vial - thiotepa

Израел - Хебрејски - Ministry of Health

mbi pharma ltd., israel - thiotepa - אבקה וממס להכנת תמיסה לאינפוזיה - thiotepa 400 mg - thiotepa

Израел - Хебрејски - Ministry of Health

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה להזרקה - human hepatitis b immunoglobulin 500 iu - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b virus (hbv) re-infection in hbv-dna negative patients ?6 months after liver transplantation for hepatitis b induced liver failure.zutectra is indicated in adults only.the concomitant use of adequate virostatic agents should be considered, if appropriate, as standard of hepatitis b re-infection prophylaxis.

Израел - Хебрејски - Ministry of Health

medison pharma ltd - cx-024414 mrna - cx-024414 mrna 1.26 mg/vial - covid-19 vaccines

Израел - Хебрејски - Ministry of Health

smart biotech ltd. - מבחנה לטיפול מקדמי בדגימת הדם קודם לבדיקתה לנוכחות נוגדנים

Израел - Хебрејски - Ministry of Health

medison pharma ltd - neratinib as maleate - טבליה - neratinib as maleate 40 mg - neratinib

Израел - Хебрејски - Ministry of Health

kamada ltd, israel - plasma protein fraction - תמיסה לאינפוזיה - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

Израел - Хебрејски - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה להכנת תמיסה לזריקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

Израел - Хебрејски - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.